HPV Prevalence | Non-Indigenous, 15 to 40 years of age (n = 1494) | Indigenous, 15 to 40 years of age (n = 655) | Â |
---|---|---|---|
 | Age-adjustedb HPV prevalence | Age adjusted to Australian populationa | Indigenous populationc |
HPV16/18 | 12.8% (10.8 to 14.8) | 12.2% (9.7 to 14.6) | 13.8% (11.1 to 16.6) |
HPV genotypes 6/11/16/18 | 15.3% (13.3 to 17.4) | 14.1% (11.5 to 16.7) | 15.9% (13.1 to 18.8) |
Cross-protection 16/18/31/45 | 17.1% (14.9 to 19.3) | 15.6% (12.9 to 18.3) | 17.4% (14.4 to 20.4) |
HRd HPV 13 typese | 30.0% (27.5 to 32.3) | 31.3% (27.7 to 34.9) | 33.2% (29.5 to 36.8) |
HR HPV 18 typesf | 33.5% (31.0 to 36.0) | 35.4% (31.8 to 39.1) | 37.5% (33.8 to 41.2) |
HR HPV-11 types (non-16/18) | 23.7% (21.3 to 26.1) | 25.9% (22.4 to 29.3) | 27.3% (23.8 to 30.9) |
HR HPV-16 types (non-16/18) | 28.6% (26.1 to 31.0) | 30.6% (27.1 to 34.2) | 32.3% (28.6 to 36.0) |
Any HPV | 41.5% (38.9 to 44.1) | 47.5% (43.6 to 51.3) | 49.3% (45.5 to 53.2) |
LRg HPV | 24.8% (22.3 to 27.2) | 28.7% (25.2 to 32.2) | 30.1% (26.5 to 33.7) |
LR only present | 8.0% (6.6 to 9.39) | 12.0% (9.41 to 14.7) | 11.9% (9.3 to 14.5) |
HPV genotypes 6/11/16/18 only | 3.5% (2.6 to 4.5) | 3.5% (2.1 to 5.0) | 4.0% (2.3 to 5.6) |
Multiple HPV types (crude prevalence) | Â | Â | Â |
   Range (min-max) | 0 to 13 | 0 to 10 | |
   None | 58.8% (56.3 to 61.3) | 50.5% (46.6 to 54.5) | |
   One | 17.5% (15.6 to 19.5) | 22.0% (18.8 to 25.3) | |
   Two | 9.1% (7.7 to 10.7) | 12.4% (9.9 to 15.1) | |
   Three | 7.0% (5.7 to 8.4) | 5.8% (4.1 to 7.9) | |
   Four or more | 7.6% (6.3 to 9.1) | 9.3% (7.2 to 11.8) |